BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 26264495)

  • 1. Galectin 3 as a guardian of the tumor microenvironment.
    Ruvolo PP
    Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectins as regulators of cell survival in the leukemia niche.
    Ruvolo PP
    Adv Biol Regul; 2019 Jan; 71():41-54. PubMed ID: 30245264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microenvironment and immunity in drug response in leukemia.
    Bakker E; Qattan M; Mutti L; Demonacos C; Krstic-Demonacos M
    Biochim Biophys Acta; 2016 Mar; 1863(3):414-426. PubMed ID: 26255027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
    Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Montalto G; Cervello M; Polesel J; Libra M; McCubrey JA
    Biochim Biophys Acta; 2016 Mar; 1863(3):438-448. PubMed ID: 26278055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
    Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
    Nicholas NS; Apollonio B; Ramsay AG
    Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of platelets in the tumor microenvironment: From solid tumors to leukemia.
    Yan M; Jurasz P
    Biochim Biophys Acta; 2016 Mar; 1863(3):392-400. PubMed ID: 26193075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.
    Ito K; Stannard K; Gabutero E; Clark AM; Neo SY; Onturk S; Blanchard H; Ralph SJ
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):763-78. PubMed ID: 22706847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of galectin-3 in cancer apoptosis.
    Nakahara S; Oka N; Raz A
    Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MSC-derived galectin 3 in the AML microenvironment.
    Ruvolo PP; Ruvolo VR; Burks JK; Qiu Y; Wang RY; Shpall EJ; Mirandola L; Hail N; Zeng Z; McQueen T; Daver N; Post SM; Chiriva-Internati M; Kornblau SM; Andreeff M
    Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):959-969. PubMed ID: 29655803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma.
    Zeinali M; Adelinik A; Papian S; Khorramdelazad H; Abedinzadeh M
    Hum Immunol; 2015 Oct; 76(10):770-4. PubMed ID: 26429330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 regulates T-cell functions.
    Hsu DK; Chen HY; Liu FT
    Immunol Rev; 2009 Jul; 230(1):114-27. PubMed ID: 19594632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of galectin‑3 in the tumor microenvironment and tumor metabolism (Review).
    Guo Y; Shen R; Yu L; Zheng X; Cui R; Song Y; Wang D
    Oncol Rep; 2020 Nov; 44(5):1799-1809. PubMed ID: 33000284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 and metastasis.
    Takenaka Y; Fukumori T; Raz A
    Glycoconj J; 2002; 19(7-9):543-9. PubMed ID: 14758078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
    Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
    Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.
    Fei F; Joo EJ; Tarighat SS; Schiffer I; Paz H; Fabbri M; Abdel-Azim H; Groffen J; Heisterkamp N
    Oncotarget; 2015 May; 6(13):11378-94. PubMed ID: 25869099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner.
    Kim SJ; Chun KH
    BMB Rep; 2020 Apr; 53(4):173-180. PubMed ID: 32172730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.